FORMULATION OF METFORMIN HYDROCHLORIDE MATRIX TABLETS BY SINTERING TECHNIQUE AND ITS EVALUATION
Journal Title: International Journal of Pharmacy and Technology - Year 2010, Vol 2, Issue 2
Abstract
Metformin hydrochloride is a biguanide, which is used as an oral hypoglycemic agent. It is a white crystalline hygroscopic drug used as an antidiabetic agent specifically for type-2 diabetes mellitus. When given, a divided dose of 0.5-3 gm daily, it increases the hepatic glucose production thereby increasing the peripheral glucose uptake and utilization and shows a significant bioavailability about 50-60%. Since metformin hydrochloride is widely chosen as the first line drug in the treatment of type2 DM, because of its minimal risk and maximum efficacy, the formulation of metformin hydrochloride matrix tablet was taken in to consideration. Matrix tablets reduce the frequency of dose administration, and are found to have increased patient compliance. A relatively recent technique called sintering technique is involved in the formulation which aims to extend the release of metformin hydrochloride from the matrix tablets. After formulation the tablets where subjected to preformulation studies, micromeritic studies, stability studies and other tablet evaluation methods. In the present world diabetes is a haunting threat for life and so, the development of metformin hydrochloride matrix tablets paves the way to increase the quality of life.
Authors and Affiliations
Flowerlet Mathew
Keywords
Related Articles
- EP ID EP129344
- DOI -
- Views 136
- Downloads 0
IN-VIVO PHARMACOKINETIC STUDIES OF SOLID DISPERSIONS OF CELECOXIB
Dissolution rate and dissolution efficiency of poorly soluble non-steroidal anti inflammatory drugs (NSAIDs) could be markedly enhanced by solid dispersion technology. Solid dispersions of celecoxib (C) are subjected to...
SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NOVEL<br /> THIAZOLOQUINAZOLINE AS NEW CLASS OF H1-ANTIHISTAMINIC AGENT
A series of novel 6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-(4'-some substituted benzylidine)-3-(4-nitrophenyl amino) thiazolo quinazoline were synthesized the reaction with appropriate aromatic aldehydes and p –nit...
VALIDATION OF REVERSED - PHASE HPLC METHOD FOR THE ESTIMATION OF CEFIXIME IN CEFIXIME ORAL SUSPENSION.
A simple, fast, precise and accurate, high performance liquid chromatographic method for estimation of Cefixime in Cefixime Oral Suspension was validated using C18 [Hypersil ODS], 4.6x250mm, 5 microns with mobile phase c...
SYNTHESIS OF NEW RING SYSTEM 6,7,8,9 TETRA HYDRO-5H-5-(2'- HYDROXY PHENYL)-2-(4'-SOME SUBSTITUTED BENZYLIDINE)-3-(4- NITROPHENYL AMINO) THIAZOLO QUINAZOLINE
A convenient synthesis of the 6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-(4'-some substituted benzylidine)-3-(4-nitrophenyl amino) thiazolo quinazoline ring system is reported. Our synthetic approach consisted of the...
CHITOSAN: A BIOCOMPATIBLE POLYMER FOR PHARMACEUTICAL APPLICATIONS IN VARIOUS DOSAGE FORMS
Chitosan is a weak cationic polysaccharide composed essentially of β(1→4) linked glucose amine units together with some acetyl glucose amine units. It is obtained by extensive deacetylation of chitin, a polysaccharide co...